Aarti Drugs Ltd.
| BSE: 524348 | Sector: Health care |
| NSE: AARTIDRUGS | ISIN Code: INE767A01016 |
| BSE 00:00 | 29 Jun | 400.30 |
-6.15 (-1.51%) |
OPEN
404.90 |
HIGH
411.50 |
LOW
397.80 |
| NSE 15:54 | 29 Jun | 400.60 |
-5.30 (-1.31%) |
OPEN
402.25 |
HIGH
411.25 |
LOW
397.50 |
| OPEN | 404.90 |
| PREVIOUS CLOSE | 406.45 |
| VOLUME | 7999 |
| 52-Week high | 749.45 |
| 52-Week low | 378.40 |
| P/E | 19.01 |
| Mkt Cap.(Rs cr) | 3,707 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Aarti Drugs Ltd. (AARTIDRUGS) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 514.85 | -6.45 | -1.24 | 15823.68 |
| Cipla | 945.60 | 0.90 | 0.10 | 13900.58 |
| Dr Reddy's Labs | 4363.30 | -11.35 | -0.26 | 13349.10 |
| Sun Pharma.Inds. | 838.15 | 10.20 | 1.23 | 12803.21 |
| Lupin | 620.20 | -13.35 | -2.11 | 11055.93 |
| Apollo Hospitals | 3715.20 | -123.50 | -3.22 | 9153.00 |
| Zydus Lifesci. | 356.05 | -1.70 | -0.48 | 7790.40 |
| Glenmark Pharma. | 389.00 | 1.55 | 0.40 | 7567.93 |
| Alkem Lab | 2972.85 | -17.45 | -0.58 | 7219.68 |
| Divi's Lab. | 3584.50 | -29.45 | -0.81 | 6798.61 |
| Torrent Pharma. | 2840.30 | -41.85 | -1.45 | 6450.83 |
| Ipca Labs. | 896.35 | -5.85 | -0.65 | 5114.11 |
| Alembic Pharma | 738.85 | 0.60 | 0.08 | 5051.44 |
| Laurus Labs | 466.60 | -2.10 | -0.45 | 4707.04 |
| Abbott India | 18964.30 | 838.20 | 4.62 | 4310.02 |
| Gland Pharma | 2652.25 | 4.60 | 0.17 | 3462.88 |
| Glaxosmi. Pharma | 1497.90 | -0.65 | -0.04 | 3193.74 |
| Granules India | 276.80 | 1.40 | 0.51 | 3134.98 |
| Sanofi India | 6420.50 | 14.35 | 0.22 | 2956.60 |
| Ajanta Pharma | 1222.85 | -18.05 | -1.45 | 2718.59 |
Quick Links for Aarti Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
